A decision aid for women at increased risk for ovarian cancer

被引:12
作者
Tiller, K [1 ]
Meiser, B
Reeson, E
Tucker, M
Andrews, L
Gaff, C
Kirk, J
Phillips, KA
Friedlander, M
机构
[1] Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia
[2] Royal N Shore Hosp, Dept Psychol Med, Sydney, NSW, Australia
[3] Royal N Shore Hosp, NSW Genet Educ Program, Sydney, NSW, Australia
[4] Genet Hlth Serv, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Familial Canc Ctr, Melbourne, Vic, Australia
[6] Westmead Hosp, Familial Canc Serv, Sydney, NSW, Australia
[7] Peter MacCallum Canc Inst, Div Haematol & Med Oncol, Melbourne, Vic 3000, Australia
[8] Peter MacCallum Canc Inst, Familial Canc Ctr, Melbourne, Vic 3000, Australia
[9] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia
关键词
decision aids; hereditary ovarian cancer; risk management options;
D O I
10.1046/j.1525-1438.2003.13018.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper reviews changes that have occurred within and without the medical profession that have fostered an increasing demand for decision aids as adjuncts to practitioners' counseling to prepare patients for decision making. In the absence of data on the efficacy of ovarian cancer screening and prophylactic strategies, decisions about optimal care are difficult for both women and their doctors. Because surveillance and preventive options are an area of great uncertainty, a decision aid has been developed specifically aimed at facilitating decisions involving ovarian cancer risk management options. This was achieved by reviewing and integrating the available literature on models of medical decision making, patient preferences for information and involvement in decision making, the utility of decision aids, and management options for ovarian cancer risk. Findings indicate that patients wish to be informed participants in the decision-making process and that decision aids are an acceptable and effective method of providing quality information in a format that facilitates an inclusive model of shared decision making. A decision aid designed for women at increased risk of ovarian cancer that facilitates informed decision making may be a valuable addition to patient support. A randomized controlled trial of this type of educational material will provide timely and much needed evidence on its acceptability and efficacy.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 76 条
[11]  
Drake E R, 1999, J Genet Couns, V8, P217, DOI 10.1023/A:1022998415890
[12]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[13]   The potential benefits of decision aids in clinical medicine [J].
Edwards, A ;
Elwyn, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :779-780
[14]   Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee [J].
Eisinger, F ;
Alby, N ;
Bremond, A ;
Dauplat, J ;
Espie, M ;
Janiaud, P ;
Kuttenn, F ;
Lebrun, JP ;
Lefranc, JP ;
Pierret, J ;
Sobol, H ;
Stoppa-Lyonnet, D ;
Thouvenin, D ;
Tristant, H ;
Feingold, J .
ANNALS OF ONCOLOGY, 1998, 9 (09) :939-950
[15]   Patients' preferences for therapy in advanced epithelial ovarian cancer: Development, testing, and application of a bedside decision instrument [J].
Elit, LM ;
Levine, MN ;
Gafni, A ;
Whelan, TJ ;
Doig, G ;
Streiner, DL ;
Rosen, B .
GYNECOLOGIC ONCOLOGY, 1996, 62 (03) :329-335
[16]  
EVANS W, 1997, MAKING CHOICES TREAT
[17]   NO NEWS IS NOT GOOD-NEWS - INFORMATION PREFERENCES OF PATIENTS WITH CANCER [J].
FALLOWFIELD, L ;
FORD, S ;
LEWIS, S .
PSYCHO-ONCOLOGY, 1995, 4 (03) :197-202
[18]   Is transvaginal ultrasound effective for screening asymptomatic women for the detection of early-stage epithelial ovarian carcinoma? [J].
Fishman, DA ;
Cohen, LS .
GYNECOLOGIC ONCOLOGY, 2000, 77 (03) :347-349
[19]  
FRIEDLANDER M, 1997, CANC FORUM, V21, P10
[20]   Shared decision making in clinical medicine: Past research and future directions [J].
Frosch, DL ;
Kaplan, RM .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1999, 17 (04) :285-294